ELOX
Geode Capital Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-19,588
| Closed | -$93.3K | – | 4812 |
|
|
2023
Q3 | $93.3K | Sell |
19,588
-671
| -3% | -$3.2K | ﹤0.01% | 4271 |
|
|
2023
Q2 | $78.8K | Buy |
20,259
+19
| +0.1% | +$74 | ﹤0.01% | 4402 |
|
|
2023
Q1 | $50.8K | Buy |
20,240
+44
| +0.2% | +$110 | ﹤0.01% | 4517 |
|
|
2022
Q4 | $36K | Sell |
20,196
-787,482
| -97% | -$1.4M | ﹤0.01% | 4678 |
|
|
2022
Q3 | $137K | Buy |
807,678
+5,265
| +0.7% | +$893 | ﹤0.01% | 4407 |
|
|
2022
Q2 | $214K | Buy |
802,413
+2,080
| +0.3% | +$555 | ﹤0.01% | 4220 |
|
|
2022
Q1 | $448K | Buy |
800,333
+2,275
| +0.3% | +$1.27K | ﹤0.01% | 3990 |
|
|
2021
Q4 | $558K | Buy |
798,058
+25,222
| +3% | +$17.6K | ﹤0.01% | 3989 |
|
|
2021
Q3 | $1.26M | Buy |
772,836
+245,529
| +47% | +$400K | ﹤0.01% | 3568 |
|
|
2021
Q2 | $1.05M | Buy |
527,307
+83,497
| +19% | +$166K | ﹤0.01% | 3568 |
|
|
2021
Q1 | $1.47M | Buy |
443,810
+24,065
| +6% | +$79.9K | ﹤0.01% | 3400 |
|
|
2020
Q4 | $1.67M | Buy |
419,745
+3,246
| +0.8% | +$12.9K | ﹤0.01% | 3175 |
|
|
2020
Q3 | $1.1M | Buy |
416,499
+19,506
| +5% | +$51.3K | ﹤0.01% | 3177 |
|
|
2020
Q2 | $1.2M | Buy |
396,993
+11,732
| +3% | +$35.5K | ﹤0.01% | 3089 |
|
|
2020
Q1 | $755K | Buy |
385,261
+39,109
| +11% | +$76.6K | ﹤0.01% | 3124 |
|
|
2019
Q4 | $2.55M | Buy |
346,152
+52,776
| +18% | +$388K | ﹤0.01% | 2863 |
|
|
2019
Q3 | $1.33M | Buy |
293,376
+22,078
| +8% | +$99.8K | ﹤0.01% | 3133 |
|
|
2019
Q2 | $2.7M | Buy |
271,298
+24,778
| +10% | +$247K | ﹤0.01% | 2757 |
|
|
2019
Q1 | $2.88M | Buy |
246,520
+8,534
| +4% | +$99.7K | ﹤0.01% | 2630 |
|
|
2018
Q4 | $2.86M | Buy |
237,986
+21,634
| +10% | +$260K | ﹤0.01% | 2558 |
|
|
2018
Q3 | $3.69M | Buy |
216,352
+13,652
| +7% | +$233K | ﹤0.01% | 2558 |
|
|
2018
Q2 | $3.46M | Buy |
+202,700
| New | +$3.46M | ﹤0.01% | 2540 |
|